{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T07:46:55Z","timestamp":1782719215314,"version":"3.54.5"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T00:00:00Z","timestamp":1777852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T00:00:00Z","timestamp":1782691200000},"content-version":"vor","delay-in-days":56,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100010552","name":"Departament de Salut, Generalitat de Catalunya","doi-asserted-by":"publisher","award":["SLT021\/21\/000030"],"award-info":[{"award-number":["SLT021\/21\/000030"]}],"id":[{"id":"10.13039\/501100010552","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["FIS PI21\/01163"],"award-info":[{"award-number":["FIS PI21\/01163"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014337","name":"Menarini Group","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100014337","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiovasc Diabetol"],"DOI":"10.1186\/s12933-026-03198-w","type":"journal-article","created":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T14:47:02Z","timestamp":1777906022000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Phenotypic clustering of newly diagnosed type 2 diabetes in a Mediterranean cohort"],"prefix":"10.1186","volume":"25","author":[{"given":"Berta","family":"Fernandez-Camins","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bogdan","family":"Vlacho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina Idalia","family":"Rojo-L\u00f3pez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minerva","family":"Granado-Casas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M\u00f2nica","family":"Gratac\u00f2s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Ortega-Bravo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Cendros-Massioui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Flavio","family":"Palmieri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandre","family":"Perera-LLuna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josep","family":"Franch-Nadal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D\u00eddac","family":"Mauricio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"The COPERNICAN Research Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,4]]},"reference":[{"key":"3198_CR1","doi-asserted-by":"publisher","first-page":"S83","DOI":"10.2337\/dc22-S006","volume":"45","author":"American Diabetes Association Professional Practice Committee","year":"2022","unstructured":"American Diabetes Association Professional Practice Committee. 6. Glycemic targets: standards of medical care in diabetes\u20142022. Diabetes Care. 2022;45:S83-96. https:\/\/doi.org\/10.2337\/dc22-S006.","journal-title":"Diabetes Care"},{"issue":"11","key":"3198_CR2","doi-asserted-by":"publisher","first-page":"1758","DOI":"10.1007\/s00125-022-05769-4","volume":"65","author":"AJ Deutsch","year":"2022","unstructured":"Deutsch AJ, Ahlqvist E, Udler MS. Phenotypic and genetic classification of diabetes. Diabetologia. 2022;65(11):1758\u201369. https:\/\/doi.org\/10.1007\/s00125-022-05769-4.","journal-title":"Diabetologia"},{"issue":"5","key":"3198_CR3","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1016\/S2213-8587(18)30051-2","volume":"6","author":"E Ahlqvist","year":"2018","unstructured":"Ahlqvist E, Storm P, K\u00e4r\u00e4j\u00e4m\u00e4ki A, Martinell M, Dorkhan M, Carlsson A, et al. Novel subgroups of adult-onset diabetes and their association with outcomes: a data-driven cluster analysis of six variables. Lancet Diabetes Endocrinol. 2018;6(5):361\u20139. https:\/\/doi.org\/10.1016\/S2213-8587(18)30051-2.","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"9","key":"3198_CR4","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1016\/S2213-8587(19)30187-1","volume":"7","author":"OP Zaharia","year":"2019","unstructured":"Zaharia OP, Strassburger K, Strom A, B\u00f6nhof GJ, Karusheva Y, Antoniou S, et al. Risk of diabetes-associated diseases in subgroups of patients with recent-onset diabetes: a 5-year follow-up study. Lancet Diabetes Endocrinol. 2019;7(9):684\u201394. https:\/\/doi.org\/10.1016\/S2213-8587(19)30187-1.","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"1","key":"3198_CR5","doi-asserted-by":"publisher","DOI":"10.1136\/bmjdrc-2020-001550","volume":"8","author":"OY Bello-Chavolla","year":"2020","unstructured":"Bello-Chavolla OY, Bahena-L\u00f3pez JP, Vargas-V\u00e1zquez A, Antonio-Villa NE, M\u00e1rquez-Salinas A, Ferm\u00edn-Mart\u00ednez CA, et al. Clinical characterization of data-driven diabetes subgroups in Mexicans using a reproducible machine learning approach. BMJ Open Diabetes Res Care. 2020;8(1):e001550. https:\/\/doi.org\/10.1136\/bmjdrc-2020-001550.","journal-title":"BMJ Open Diabetes Res Care"},{"issue":"1","key":"3198_CR6","doi-asserted-by":"publisher","DOI":"10.1136\/bmjdrc-2020-001506","volume":"8","author":"RM Anjana","year":"2020","unstructured":"Anjana RM, Baskar V, Nair ATN, Jebarani S, Siddiqui MK, Pradeepa R, et al. Novel subgroups of type 2 diabetes and their association with microvascular outcomes in an Asian Indian population: a data-driven cluster analysis: the INSPIRED study. BMJ Open Diabetes Res Care. 2020;8(1):e001506. https:\/\/doi.org\/10.1136\/bmjdrc-2020-001506.","journal-title":"BMJ Open Diabetes Res Care"},{"issue":"9","key":"3198_CR7","doi-asserted-by":"publisher","first-page":"1982","DOI":"10.1007\/s00125-021-05490-8","volume":"64","author":"RC Slieker","year":"2021","unstructured":"Slieker RC, Donnelly LA, Fitipaldi H, Bouland GA, Giordano GN, kerlund M, et al. Replication and cross-validation of type 2 diabetes subtypes based on clinical variables: an IMI-RHAPSODY study. Diabetologia. 2021;64(9):1982\u20139. https:\/\/doi.org\/10.1007\/s00125-021-05490-8.","journal-title":"Diabetologia"},{"issue":"7","key":"3198_CR8","doi-asserted-by":"publisher","DOI":"10.3390\/jcm9072083","volume":"9","author":"H Tanabe","year":"2020","unstructured":"Tanabe H, Saito H, Kudo A, Machii N, Hirai H, Maimaituxun G, et al. Factors associated with risk of diabetic complications in novel cluster-based diabetes subgroups: a Japanese retrospective cohort study. J Clin Med. 2020;9(7):2083. https:\/\/doi.org\/10.3390\/jcm9072083.","journal-title":"J Clin Med"},{"issue":"1","key":"3198_CR9","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/S2213-8587(18)30316-4","volume":"7","author":"X Zou","year":"2019","unstructured":"Zou X, Zhou X, Zhu Z, Ji L. Novel subgroups of patients with adult-onset diabetes in Chinese and US populations. Lancet Diabetes Endocrinol. 2019;7(1):9\u201311. https:\/\/doi.org\/10.1016\/S2213-8587(18)30316-4.","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"6","key":"3198_CR10","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1016\/S2213-8587(19)30087-7","volume":"7","author":"JM Dennis","year":"2019","unstructured":"Dennis JM, Shields BM, Henley WE, Jones AG, Hattersley AT. Disease progression and treatment response in data-driven subgroups of type 2 diabetes compared with models based on simple clinical features: an analysis using clinical trial data. Lancet Diabetes Endocrinol. 2019;7(6):442\u201351. https:\/\/doi.org\/10.1016\/S2213-8587(19)30087-7.","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"1","key":"3198_CR11","doi-asserted-by":"publisher","DOI":"10.1038\/s43856-023-00360-3","volume":"3","author":"S Misra","year":"2023","unstructured":"Misra S, Wagner R, Ozkan B, Sch\u00f6n M, Sevilla-Gonzalez M, Prystupa K, et al. Precision subclassification of type 2 diabetes: a systematic review. Commun Med. 2023;3(1):138. https:\/\/doi.org\/10.1038\/s43856-023-00360-3.","journal-title":"Commun Med"},{"issue":"8003","key":"3198_CR12","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1038\/s41586-024-07019-6","volume":"627","author":"K Suzuki","year":"2024","unstructured":"Suzuki K, Hatzikotoulas K, Southam L, Taylor HJ, Yin X, Lorenz KM, et al. Genetic drivers of heterogeneity in type 2 diabetes pathophysiology. Nature. 2024;627(8003):347\u201357. https:\/\/doi.org\/10.1038\/s41586-024-07019-6.","journal-title":"Nature"},{"issue":"12","key":"3198_CR13","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2023-083825","volume":"14","author":"B Fernandez-Camins","year":"2024","unstructured":"Fernandez-Camins B, Vlacho B, Canudas A, Ortega M, Granado-Casas M, Perera-LLuna A, et al. Characterisation of type 2 diabetes subgroups at diagnosis: the COPERNICAN prospective observational cohort study protocol. BMJ Open. 2024;14(12):e083825. https:\/\/doi.org\/10.1136\/bmjopen-2023-083825.","journal-title":"BMJ Open"},{"issue":"10","key":"3198_CR14","doi-asserted-by":"publisher","first-page":"3588","DOI":"10.3390\/jcm14103588","volume":"14","author":"B Taurbekova","year":"2025","unstructured":"Taurbekova B, Sarsenov R, Yaqoob MM, Atageldiyeva K, Semenova Y, Fazli S, et al. Cluster Analysis in Diabetes Research: A Systematic Review Enhanced by a Cross-Sectional Study. J Clin Med. 2025;14(10):3588. https:\/\/doi.org\/10.3390\/jcm14103588.","journal-title":"J Clin Med"},{"key":"3198_CR15","unstructured":"Diabetes Trials Unit, University of Oxford. HOMA2 Calculator, version [Version, 2.2.3]. Available at: https:\/\/www.dtu.ox.ac.uk\/homacalculator\/."},{"key":"3198_CR16","unstructured":"R Core Team. R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria."},{"issue":"2","key":"3198_CR17","doi-asserted-by":"publisher","DOI":"10.1136\/bmjdrc-2021-002731","volume":"10","author":"DH Christensen","year":"2022","unstructured":"Christensen DH, Nicolaisen SK, Ahlqvist E, Stidsen JV, Nielsen JS, Hojlund K, et al. Type 2 diabetes classification: a data-driven cluster study of the danish centre for strategic research in type 2 diabetes (DD2) cohort. BMJ Open Diabetes Res Care. 2022;10(2):e002731. https:\/\/doi.org\/10.1136\/bmjdrc-2021-002731.","journal-title":"BMJ Open Diabetes Res Care"},{"issue":"6","key":"3198_CR18","doi-asserted-by":"publisher","DOI":"10.1136\/bmjdrc-2024-004493","volume":"12","author":"VV Bjark\u00f8","year":"2024","unstructured":"Bjark\u00f8 VV, Haug EB, Langhammer A, Ruiz PLD, Carlsson S, Birkeland KI, et al. Clinical utility of novel diabetes subgroups in predicting vascular complications and mortality: up to 25 years of follow-up of the HUNT Study. BMJ Open Diabetes Res Care. 2024;12(6):e004493. https:\/\/doi.org\/10.1136\/bmjdrc-2024-004493.","journal-title":"BMJ Open Diabetes Res Care"},{"issue":"11","key":"3198_CR19","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2025-101284","volume":"15","author":"SM Dsouza","year":"2025","unstructured":"Dsouza SM, Sulaiman F, Abdul F, Mulla F, Ahmed FS, AlSharhan M, et al. Aetiological clustering of newly diagnosed type 2 diabetes using machine learning: a retrospective cross-sectional study in Dubai, UAE. BMJ Open. 2025;15(11):e101284. https:\/\/doi.org\/10.1136\/bmjopen-2025-101284.","journal-title":"BMJ Open"},{"issue":"1","key":"3198_CR20","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1038\/s41591-020-1116-9","volume":"27","author":"R Wagner","year":"2021","unstructured":"Wagner R, Heni M, Tab\u00e1k AG, Machann J, Schick F, Randrianarisoa E, et al. Pathophysiology-based subphenotyping of individuals at elevated risk for type 2 diabetes. Nat Med. 2021;27(1):49\u201357. https:\/\/doi.org\/10.1038\/s41591-020-1116-9.","journal-title":"Nat Med"},{"issue":"5","key":"3198_CR21","doi-asserted-by":"publisher","first-page":"e2106","DOI":"10.1210\/clinem\/dgaa962","volume":"106","author":"MP Bancks","year":"2021","unstructured":"Bancks MP, Bertoni AG, Carnethon M, Chen H, Cotch MF, Gujral UP, et al. Association of diabetes subgroups with race\/ethnicity, risk factor burden and complications: the MASALA and MESA studies. J Clin Endocrinol Metab. 2021;106(5):e2106\u201315. https:\/\/doi.org\/10.1210\/clinem\/dgaa962.","journal-title":"J Clin Endocrinol Metab"},{"issue":"8","key":"3198_CR22","doi-asserted-by":"publisher","first-page":"1346","DOI":"10.1111\/jdi.13494","volume":"12","author":"X Xiong","year":"2021","unstructured":"Xiong X, Yang Y, Wei L, Xiao Y, Li L, Sun L. Identification of two novel subgroups in patients with diabetes mellitus and their association with clinical outcomes: a two-step cluster analysis. J Diabetes Investig. 2021;12(8):1346\u201358. https:\/\/doi.org\/10.1111\/jdi.13494.","journal-title":"J Diabetes Investig"},{"issue":"1","key":"3198_CR23","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1007\/s00125-021-05543-y","volume":"65","author":"RB Prasad","year":"2022","unstructured":"Prasad RB, Asplund O, Shukla SR, Wagh R, Kunte P, Bhat D, et al. Subgroups of patients with young-onset type 2 diabetes in India reveal insulin deficiency as a major driver. Diabetologia. 2022;65(1):65\u201378. https:\/\/doi.org\/10.1007\/s00125-021-05543-y.","journal-title":"Diabetologia"},{"key":"3198_CR24","doi-asserted-by":"publisher","unstructured":"Al-Thani NM, Zaghlool SB, Abou-Samra AB, Suhre K, Albagha OME. Subtyping of Type 2 Diabetes from a large Middle Eastern Biobank: Implications for Precision Medicine [Internet]. Genetic and Genomic Medicine; 2024 [cited 2026 Mar 15]. Available from: http:\/\/medrxiv.org\/lookup\/doi\/https:\/\/doi.org\/10.1101\/2024.12.26.24319530","DOI":"10.1101\/2024.12.26.24319530"}],"container-title":["Cardiovascular Diabetology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12933-026-03198-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12933-026-03198-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12933-026-03198-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T07:14:18Z","timestamp":1782717258000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12933-026-03198-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,4]]},"references-count":24,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["3198"],"URL":"https:\/\/doi.org\/10.1186\/s12933-026-03198-w","relation":{},"ISSN":["1475-2840"],"issn-type":[{"value":"1475-2840","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,4]]},"assertion":[{"value":"17 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The present study complies with all the ethical requirements and with the protection of the participant subjects as it complies with the legal ethical Spanish regulation (Real Decreto 957\/2020 and the Biomedical Investigation Law 14\/2007, 3 July) and the Declaration of Helsinki in its last revision. This protocol was evaluated by the Ethics Committee (CEI) before the inclusion of the patients (Hospital de la Santa Creu i Sant Pau Ethics Committee, ref. HSCSP 21\/369 (OBS) dated 17 July 2021.; Ethics Committee for drug research (CEIm) at IDIAP Jordi Gol, CEIm ref. 21\/266-P dated 15 December 2021; University Hospital of Bellvitge Ethics Committee for Research, ref. PR438\/21 (CSI 21\/86) dated 09 February 2022). The study protocol was registered on ClinicalTrials.gov with Trial Registration Number NCT05333718.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"186"}}